KKR & Co. Inc. (NYSE:KKR – Get Free Report) was upgraded by stock analysts at Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.
A number of other brokerages also recently issued reports on KKR. Wells Fargo & Company cut their price target on shares of KKR & Co. Inc. from $141.00 to $120.00 and set an “overweight” rating for the company in a report on Tuesday, April 8th. Keefe, Bruyette & Woods reduced their price objective on shares of KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating on the stock in a report on Monday, January 13th. HSBC raised shares of KKR & Co. Inc. from a “hold” rating to a “buy” rating and lowered their target price for the stock from $170.00 to $119.00 in a research note on Tuesday. JMP Securities cut their price objective on KKR & Co. Inc. from $165.00 to $150.00 and set a “market outperform” rating on the stock in a report on Tuesday, April 8th. Finally, TD Cowen dropped their price objective on shares of KKR & Co. Inc. from $183.00 to $126.00 and set a “buy” rating for the company in a report on Wednesday, April 9th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, KKR & Co. Inc. currently has a consensus rating of “Moderate Buy” and a consensus target price of $144.93.
View Our Latest Stock Analysis on KKR
KKR & Co. Inc. Stock Down 1.9 %
Insider Buying and Selling
In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total value of $197,760,000.00. Following the completion of the sale, the insider now owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. This trade represents a 23.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 39.34% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. McIlrath & Eck LLC purchased a new position in KKR & Co. Inc. in the 4th quarter valued at about $26,000. Hanson & Doremus Investment Management bought a new position in KKR & Co. Inc. during the 4th quarter valued at $27,000. Crews Bank & Trust acquired a new stake in shares of KKR & Co. Inc. in the 4th quarter valued at about $30,000. Mascagni Wealth Management Inc. acquired a new stake in KKR & Co. Inc. during the fourth quarter valued at approximately $31,000. Finally, Pilgrim Partners Asia Pte Ltd bought a new position in KKR & Co. Inc. during the fourth quarter worth $34,000. 76.26% of the stock is currently owned by hedge funds and other institutional investors.
KKR & Co. Inc. Company Profile
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Featured Articles
- Five stocks we like better than KKR & Co. Inc.
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- When to Sell a Stock for Profit or Loss
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.